Vietnam set to complete first Covid-19 vaccine trials by 2022
Human trials of Nanocovax, the first Covid-19 vaccine in Vietnam developed by Nanogen Pharmaceutical Biotechnology JSC, began Thursday morning with two men and a woman in their 20s getting shots at Vietnam Military Medical University in Hanoi.
Nanogen said it would complete the first phase in February next year in Hanoi, testing the vaccine with a group of 60 volunteers in collaboration with Vietnam Military Medical University. The second phase is scheduled to start within February next year and last until August, with 400-600 volunteers aged 12-75 vaccinated. The final phase will last until February 2022, with 1,500-3,000 volunteers aged from 12 to 75 injected with the vaccine in either India, Indonesia, or Bangladesh.
Chi Le
